Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Apr
11
2024
ITU Applicants Beware: Federal Courts Have Jurisdiction Over Pending Trademark Applications McDermott Will & Emery
Apr
16
2024
This Week in 340B: April 9 – April 15, 2024 McDermott Will & Emery
Jan
8
2019
FDA 2018 Year in Review: Advertising and Promotion McDermott Will & Emery
Jan
14
2019
Congressional Cannabis Caucus – 116th Congress McDermott Will & Emery
Jun
2
2014
Federal Court Vacates 340B Rule Regarding Orphan Drugs McDermott Will & Emery
Feb
7
2019
2018 Digital Health Year in Review: Focus on Care Coordination and Reimbursement McDermott Will & Emery
Feb
22
2019
Annual EU Competition Review 2018 McDermott Will & Emery
Sep
26
2014
Merck Boosts Life Sciences Industry with Sigma-Aldrich Acquisition McDermott Will & Emery
Oct
28
2014
CMS Releases Preliminary 2015 Clinical Laboratory Fee Schedule Rates McDermott Will & Emery
Apr
29
2019
Health Care Enforcement Quarterly Roundup | Q1 2019 McDermott Will & Emery
Feb
9
2015
Out-of-Market Divestiture Required to Resolve Competitive Concerns McDermott Will & Emery
Aug
21
2019
Third Circuit Upholds Decision Blocking Trump Administration’s Birth Control Rules McDermott Will & Emery
Sep
4
2019
Life Sciences Company Settles Regulation FD Charges With SEC McDermott Will & Emery
Jul
9
2015
FDA Announces New Menu Labeling Compliance Date McDermott Will & Emery
Sep
27
2019
McDermottPlus Check-Up: September 27, 2019 McDermott Will & Emery
Oct
20
2015
D.C. Federal Court Rejects HHS Interpretation of 340B Program’s Orphan Drug Rule McDermott Will & Emery
Nov
6
2019
New Arguments In IPR Reply Are Out Of The Frying Pan, Into The Fryer McDermott Will & Emery
Nov
15
2019
McDermottPlus Check-Up: November 15, 2019 McDermott Will & Emery
Nov
27
2019
Only Director May Decide Merits Of Certificate Of Correction McDermott Will & Emery
Jan
19
2016
National Transportation Safety Board Targets Impaired Driving McDermott Will & Emery
Aug
12
2021
The Skinny Label That Wasn’t—Federal Circuit Reinstates Induced Infringement Verdict McDermott Will & Emery
Feb
12
2020
Analyzing the President’s FY 2021 Budget: Key HHS Proposals McDermott Will & Emery
Mar
7
2020
Mississippi Supreme Court Rejects ‘Passage of Title’ DTC Theory McDermott Will & Emery
Dec
16
2021
Obvious to Try Requires Reasonable Expectation of Success Tethered to Claimed Invention McDermott Will & Emery
Aug
17
2016
FDA Issues Final Rule on Food Ingredients that May Be Generally Recognized as Safe (GRAS) McDermott Will & Emery
Apr
10
2022
McDermottPlus Check-Up: April 8, 2022 McDermott Will & Emery
Nov
17
2016
FDA Hosts Public Meeting on Off-Label Communications McDermott Will & Emery
Apr
21
2022
TTB Issues Four-Part Series on Health-Related Alcohol Marketing Claims McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins